Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting

References

• Anhorn MG, Mahler HC, Langer K. (2008a). Freeze drying of human serum albumin (HSA) nanoparticles with different excipients. Int J Pharm, 363, 162–169.
   PubMed Web of Science ®Google Scholar
• Anhorn MG, Wagner S, Kreuter J, Langer K, von Briesen H. (2008b). Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles. Bioconjug Chem, 19, 2321–2331.
   PubMed Web of Science ®Google Scholar
• Bejugam NK, Uddin AN, Gayakwad SG, D’Souza MJ. (2008). Formulation and evaluation of albumin microspheres and its enteric coating using a spray-dryer. J Microencapsul, 25, 577–583.
   PubMed Web of Science ®Google Scholar
• Bhojani MS, Van Dort M, Rehemtulla A, Ross BD. (2010). Targeted imaging and therapy of brain cancer using theranostic nanoparticles. Mol Pharm, 7, 1921–1929.
   PubMed Web of Science ®Google Scholar
• Bilati U, Allémann E, Doelker E. (2005). Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci, 24, 67–75.
   PubMed Web of Science ®Google Scholar
• Chablani L, Tawde SA, D’Souza MJ. (2012). Spray-dried microparticles: a potential vehicle for oral delivery of vaccines. J Microencapsul, 29, 388–397.
   PubMed Web of Science ®Google Scholar
• Chen D, Zhang Z, Cao J, Zhang D, Jia B. (2010). [Effect of glucosamine hydrochloride capsules on articular cartilage of rabbit knee joint in osteoarthritis]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 24, 287–291.
   PubMedGoogle Scholar
• Chorny M, Fishbein I, Danenberg HD, Golomb G. (2002). Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. J Control Release, 83, 389–400.
   PubMed Web of Science ®Google Scholar
• Cortes J, Saura C. (2010). Nanoparticle albumin-bound (nab™)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer. EJC Supplements, 8, 1–10.
   Web of Science ®Google Scholar
• Desai ND. (2007). Nanoparticle albumin bound (nab) technology: targeting tumors through the endothelial gp60 receptor and SPARC. Nanomedicine, 337–346.
   Google Scholar
• El-Leithy ES, Shaker DS, Ghorab MK, Abdel-Rashid RS. (2010). Optimization and characterization of diclofenac sodium microspheres prepared by a modified coacervation method. Drug Discov Ther, 4, 208–216.
   PubMedGoogle Scholar
• Gayakwad SG, Bejugam NK, Akhavein N, Uddin NA, Oettinger CE, D’Souza MJ. (2009). Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres. J Microencapsul, 26, 692–700.
   PubMed Web of Science ®Google Scholar
• Greish K, Iyer A, Fang J, Kawasuji M, Maeda H. (2006). Enhanced Permeability and Retention (EPR) Effect and Tumor-Selective Delivery of Anticancer Drugs. Delivery of protein and peptide drugs in cancer. 37–52.
   Google Scholar
• Greish K. (2010). Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. In: Grobmeyer SR, Moudgil BM. Cancer nanotechnology: methods and protocols. New York, NY: Humana Press.
   Google Scholar
• Hadjiioannou TP, Christian GD, Koupparis MA. (1993). Quantitative calculations in pharmaceutical practice and research. New York, NY: VCH Publishers Inc.
   Google Scholar
• Higuchi T. (1963). Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 52, 1145–1149.
   PubMed Web of Science ®Google Scholar
• Hixson AW, Crowell JH. (1931). Dependence of reaction velocity upon surface and agitation: I-theoretical consideration. Ind Eng Chem, 23, 923–931.
   Google Scholar
• Hornig S, Bunjes H, Heinze T. (2009). Preparation and characterization of nanoparticles based on dextran-drug conjugates. J Colloid Interface Sci, 338, 56–62.
   PubMed Web of Science ®Google Scholar
• Janib SM, Moses AS, MacKay JA. (2010). Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev, 62, 1052–1063.
   PubMed Web of Science ®Google Scholar
• Jones AK, Bejugam NK, Nettey H, Addo R, D’Souza MJ. (2011). Spray-dried doxorubicin-albumin microparticulate systems for treatment of multidrug resistant melanomas. J Drug Target, 19, 427–433.
   PubMed Web of Science ®Google Scholar
• Kalaria DR, Sharma G, Beniwal V, Ravi Kumar MN. (2009). Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats. Pharm Res, 26, 492–501.
   PubMed Web of Science ®Google Scholar
• Kheirolomoom A, Mahakian LM, Lai CY, Lindfors HA, Seo JW, Paoli EE, Watson KD, Haynam EM, Ingham ES, Xing L, Cheng RH, Borowsky AD, Cardiff RD, Ferrara KW. (2010). Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity. Mol Pharm, 7, 1948–1958.
   PubMed Web of Science ®Google Scholar
• Korsemeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. (1983). Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm, 15, 25–35.
   Web of Science ®Google Scholar
• Krishna R, Mayer LD. (2000). Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci, 11, 265–283.
   PubMed Web of Science ®Google Scholar
• Liu Y, Miyoshi H, Nakamura M. (2007). Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer, 120, 2527–2537.
   PubMed Web of Science ®Google Scholar
• Masotti A, Vicennati P, Boschi F, Calderan L, Sbarbati A, Ortaggi G. (2008). A novel near-infrared indocyanine dye-polyethylenimine conjugate allows DNA delivery imaging in vivo. Bioconjug Chem, 19, 983–987.
   PubMed Web of Science ®Google Scholar
• Miele E, Spinelli GP, Miele E, Tomao F, Tomao S. (2009). Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int J Nanomedicine, 4, 99–105.
   PubMed Web of Science ®Google Scholar
• Mohan P, Rapoport N. (2010). Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking. Mol Pharm, 7, 1959–1973.
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol, 2, 751–760.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Labhasetwar V. (2003). Nanotech approaches to drug delivery and imaging. Drug Discov Today, 8, 1112–1120.
   PubMed Web of Science ®Google Scholar
• Saxena V, Sadoqi M, Shao J. (2006). Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice. Int J Pharm, 308, 200–204.
   PubMed Web of Science ®Google Scholar
• Shastri PN, Ubale RV, D’Souza MJ. (2012). Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles. Drug Dev Ind Pharm. DOI: 10.3109/03639045.2012.664148
   PubMed Web of Science ®Google Scholar
• Shen Z, Wei W, Zhao Y, Ma G, Dobashi T, Maki Y, Su Z, Wan J. (2008). Thermosensitive polymer-conjugated albumin nanospheres as thermal targeting anti-cancer drug carrier. Eur J Pharm Sci, 35, 271–282.
   PubMed Web of Science ®Google Scholar
• Shen Z, Li Y, Kohama K, Oneill B, Bi J. (2011). Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres. Pharmacol Res, 63, 51–58.
   PubMed Web of Science ®Google Scholar
• Sun C, Lee JS, Zhang M. (2008). Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev, 60, 1252–1265.
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Michaelis M, Rothweiler F, Knobloch T, Sithisarn P, Cinatl J, Kreuter J. (2011). Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells. Int J Pharm, 406, 128–134.
   PubMed Web of Science ®Google Scholar
• Veiseh O, Gunn JW, Zhang M. (2010). Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev, 62, 284–304.
   PubMed Web of Science ®Google Scholar
• Vijayaraghavalu S, Raghavan D, Labhasetwar V. (2007). Nanoparticles for delivery of chemotherapeutic agents to tumors. Curr Opin Investig Drugs, 8, 477–484.
   PubMed Web of Science ®Google Scholar
• Vogel SM, Minshall RD, Pilipovic M, Tiruppathi C, Malik AB. (2001). Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein. Am J Physiol Lung Cell Mol Physiol, 281, L1512–L1522.
   PubMed Web of Science ®Google Scholar
• Wang G, Siggers K, Zhang S, Jiang H, Xu Z, Zernicke RF, Matyas J, Uludag H. (2008). Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating. Pharm Res, 25, 2896–2909.
   PubMed Web of Science ®Google Scholar
• Wang M, Thanou M. (2010). Targeting nanoparticles to cancer. Pharmacol Res, 62, 90–99.
   PubMed Web of Science ®Google Scholar
• Weissleder R. (2001). A clearer vision for in vivo imaging. Nat Biotechnol, 19, 316–317.
   PubMed Web of Science ®Google Scholar